Concepedia

Author

Henriette Golcher

Friedrich-Alexander-Universität Erlangen-NürnbergORCID

Also Known As

C Vay, G Weber, G. Lahmer, G. Weber, Golcher, H., H Golcher, H. Golcher, Henriette Golcher, Henriette M. B. Golcher, Henriette M.B. GOLCHER

56

Publications

1.9K

Citations

20

H-Index

26

Concepts

All Affiliations

Friedrich-Alexander-Universität Erlangen-NürnbergUniversitätsklinikum ErlangenGoethe University FrankfurtUniversity Hospital FrankfurtUniversity Hospital Magdeburg
HG

About

Henriette Golcher is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

231

2

Health Sciences

1

1

108

3

Natural Sciences

1

1

33

4

Biochemistry

1

1

33

5

Biomolecular Engineering

1

1

33

Henriette Golcher

×

21

Publications

1.7K

Citations

16

H-Index

YearCitations

Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer

Henriette Golcher, Thomas Brunner, Helmut Witzigmann,

Strahlentherapie und Onkologie

2014

327

Interrupted or Continuous Slowly Absorbable Sutures For Closure of Primary Elective Midline Abdominal Incisions

Christoph M. Seiler, Thomas Brückner, Markus K. Diener,

Annals of Surgery

2009

241

Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers

Kinga Tóth, Ferenc Sípos, Alexandra Kalmár,

PLoS ONE

2012

186

Clinical Predictors and Algorithm for the Genetic Diagnosis of Pheochromocytoma Patients

Zoran Erlic, Lisa Rybicki, Mariola Pęczkowska,

Clinical Cancer Research

2009

172

Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10

Karin Frank‐Raue, Lisa Rybicki, Zoran Erlic,

Human Mutation

2010

149

Randomized phase III trial of induction chemotherapy followed by chemoradiotherapy or chemotherapy alone for nonresectable locally advanced pancreatic cancer: First results of the CONKO-007 trial.

Rainer Fietkau, Michael Ghadimi, Robert Grützmann,

Journal of Clinical Oncology

2022

108

Better Function With a Colonic J-Pouch or a Side-to-end Anastomosis?

Yann Parc, R. Ruppert, Alois Fuerst,

Annals of Surgery

2019

59

Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplinary Working Group Gastrointestinal Tumours (AIO, ARO, and CAO)

Thomas Brunner, Gerhard G. Grabenbauer, Thomas Meyer,

BMC Cancer

2007

57

R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial

Rainer Fietkau, Robert Grützmann, Uwe A. Wittel,

Strahlentherapie und Onkologie

2020

56

Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy

Henriette Golcher, Thomas Brunner, Gerhard G. Grabenbauer,

European Journal of Surgical Oncology

2008

55

Page 1